aunceston chickpea study

Completed

• Conditions: Cardiovascular disease risk; Cardiovascular - Normal development and function of the cardiovascular system; Glucose intolerance

• Registration Number: ACTRN12605000605695
• Lead Sponsor: School of Human Life Sciences, University of Tasmania

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Middle-aged, healthy,recruited by newspaper advertisement who were willing to eat a chickpea supplemented diet for a 5 week period.

Exclusion Criteria

Those on lipid-lowering or anti-diabetic medication; intolerant to chickpea or wheat.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum lipid and lipoprotein levels[Measured at the start and end of each 5 week dietary period];Plasma glucose levels[Measured at the start and end of each 5 week dietary period];Serum insulin levels[Measured at the start and end of each 5 week dietary period]

Secondary Outcome Measures

Name	Time	Method
4-day weighed food diary assessment of dietary intake during final week of each diet period.[]